chr15:74315213:> Detail (hg19) (PML)

Information

Genome

Assembly Position
hg19 chr15:74,315,213-74,315,219
hg38 chr15:74,022,872-74,022,878 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
acute promyelocytic leukemia Tretinoin B Predictive Supports Resistance Somatic 4 23670176 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
Mutations in the B2 domain of PML in the PML-RARa fusion have been shown to be associated with resis... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr15:74,315,213-74,315,219
Variant Type
snv
Variant (CIViC) (CIViC Variant)
B2 DOMAIN MUTATION
Transcript 1 (CIViC Variant)
ENST00000268058.3
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/461
Summary (CIViC Variant)
The B2 domain in PML is the binding site for ATRA. Point mutations in this region have been associated with ATRA resistance in patients with APL.
Genome browser